Eating on a GLP-1: the playbook

The medication kills your appetite. It does not tell you what to do with the appetite you have left — and that decision determines whether you lose fat or lose fat and a worrying amount of muscle. Here's the playbook, built from the trials rather than the influencers.

The problem nobody puts on the label

GLP-1s produce dramatic weight loss — that part is settled science. What gets less airtime: a meaningful share of the pounds lost are lean mass, not fat. In the DXA body-composition substudy of the landmark semaglutide trial (STEP 1, New England Journal of Medicine), participants lost about 10% of their lean mass alongside roughly 19% of their fat mass — proportionally, body composition improved, but in absolute terms real muscle went with the fat. That's not unique to GLP-1s — rapid weight loss by any method costs muscle — but the appetite suppression is so effective that people quietly stop eating the very things that protect it.

Losing muscle while losing weight is how you end up lighter but weaker, with a slower metabolism and a harder maintenance phase. The fix is not complicated. It's two things, done consistently.

Fix one: protein becomes the first bite, every time

When your appetite shrinks to a fraction of normal, whatever you eat first is most of what you eat. Make it protein. The research consensus is that higher protein intake preserves lean mass during caloric restriction, and a widely cited meta-analysis in the British Journal of Sports Medicine (Morton et al.) found muscle benefits from protein climb until roughly 1.6 grams per kilogram of body weight per day.

In food terms, for someone around 200 lb (91 kg), that's a target in the neighborhood of 110–145 grams a day — which is genuinely hard on a suppressed appetite. Practical moves that survive week one:

Fix two: resistance training is not optional

Protein protects muscle; training tells your body to keep it. The evidence for pairing exercise with GLP-1-class medication is direct: a randomized trial in the New England Journal of Medicine (Lundgren et al.) compared liraglutide, exercise, and the combination — the combination preserved the healthiest body composition and held onto results best. Separately, muscle-strengthening activity on its own is associated with lower all-cause mortality at surprisingly modest doses (30–60 minutes a week, per the meta-analysis by Momma et al. in the British Journal of Sports Medicine).

Two to three short sessions a week — squat, hinge, push, pull, carry, with anything heavy enough to be challenging — is the evidence-aligned minimum, not a bodybuilding program.

Week one, when appetite falls off a cliff

The maintenance question nobody wants to think about yet

Trials that stop the medication show substantial regain for most participants — which is the strongest argument that the habits built during the medication phase are the actual product. The people who keep results are, overwhelmingly, the people who kept the protein habit, kept training, and treated the drug as scaffolding rather than the building. That's the entire reason this site says diet first, meds as tools.

The money angle: whatever you pay for the medication — $149 or $500 a month, see the True-Cost Index — the protein and the training are what convert that spend into a result that survives the last dose. The cheapest insurance on a GLP-1 investment costs about as much as eggs and a pair of dumbbells.

Sources

Educational content built on the cited literature — not medical or nutrition advice for your situation, and not a substitute for the clinician who prescribed your medication. Full standards: editorial policy.